Older patients with diabetic macular edema have a weaker response to anti-VEGF treatment, according to a presentation at ...
Additionally, the prognosis of macular edema may help clinicians evaluate renal function, investigators reported ...
In addition to comparable BCVA levels, the researchers concluded that the PDS implant “provides effective, durable, and ...
Hosted on MSN1mon
DURAVYU shows promise in Phase 2 trial for eye diseaseDME is a significant public health concern ... EyePoint has also appointed Dr. Reginald J. Sanders, a renowned retina specialist, to its Board of Directors. Analysts from Citi have initiated ...
Combined company expected to trade on Nasdaq under “KLRS” after closingPALO ALTO, Calif. and LEXINGTON, Mass., March 12, 2025 ...
Susvimo is now available to U.S. retina specialists and their patients with DME. “Susvimo presents a unique, convenient treatment alternative to routine eye injections for people with a ...
“The promising results for patients with DME and nAMD suggest that faricimab may also be efficacious in other retinal vascular diseases,” they wrote. Due to the multifactorial pathogenesis of ...
Successful 2024 marked by significant clinical advancements across Oculis’ late-stage and highly differentiated clinical pipeline targeting ...
Announces several updates to enhance and accelerate AXPAXLI registrational program in wet AMD, potentially supporting label flexibility of 6-12 ...
4-6 Susvimo is now available to US retina specialists and their patients with DME. “Susvimo presents a unique, convenient treatment alternative to routine eye injections for people with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback